标题
Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma
作者
关键词
-
出版物
npj Breast Cancer
Volume 7, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-07-22
DOI
10.1038/s41523-021-00302-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Survival Outcomes for Metaplastic Breast Cancer Differ by Histologic Subtype
- (2021) Audree B. Tadros et al. ANNALS OF SURGICAL ONCOLOGY
- Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
- (2020) Kimberly H. Allison et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Selecting Node-Positive Patients for Axillary Downstaging with Neoadjuvant Chemotherapy
- (2020) Giacomo Montagna et al. ANNALS OF SURGICAL ONCOLOGY
- Metaplastic breast cancer: Prognostic and therapeutic considerations
- (2020) Giovanni Corso et al. JOURNAL OF SURGICAL ONCOLOGY
- Tumor-infiltrating lymphocyte abundance and programmed death-ligand 1 expression in metaplastic breast carcinoma: implications for distinct immune microenvironments in different metaplastic components
- (2020) Huang-Chun Lien et al. VIRCHOWS ARCHIV
- Metaplastic breast carcinoma: a clinical-pathologic study of 97 cases with subset analysis of response to neoadjuvant chemotherapy
- (2019) Min Han et al. MODERN PATHOLOGY
- Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy
- (2019) Zahraa Al-Hilli et al. BREAST CANCER RESEARCH AND TREATMENT
- Mutational Diversity and Therapy Response in Breast Cancer: A Sequencing Analysis in the Neoadjuvant GeparSepto Trial
- (2019) Sibylle Loibl et al. CLINICAL CANCER RESEARCH
- Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database
- (2018) Cecilia T. Ong et al. ANNALS OF SURGICAL ONCOLOGY
- High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breast
- (2018) Guillaume Bataillon et al. HISTOPATHOLOGY
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
- (2018) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy
- (2018) Carsten Denkert et al. LANCET ONCOLOGY
- Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010–2014
- (2018) Mary C. Schroeder et al. ONCOLOGIST
- Immunoprofile of metaplastic carcinomas of the breast
- (2017) Emad A Rakha et al. HISTOPATHOLOGY
- Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype
- (2017) W. Fraser Symmans et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
- (2017) Ahmet Zehir et al. NATURE MEDICINE
- A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma
- (2016) Ashley Cimino-Mathews et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study
- (2016) Anita Mamtani et al. ANNALS OF SURGICAL ONCOLOGY
- Imaging overview of metaplastic carcinomas of the breast: a large study of 71 cases
- (2016) Fiona Langlands et al. BRITISH JOURNAL OF RADIOLOGY
- Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes
- (2016) Sasha E. Stanton et al. JAMA Oncology
- Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)
- (2015) Donavan T. Cheng et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group
- (2015) Elena Provenzano et al. MODERN PATHOLOGY
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- Tumor Biology Correlates With Rates of Breast-Conserving Surgery and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer
- (2014) Judy C. Boughey et al. ANNALS OF SURGERY
- Survival Outcomes of Metaplastic Breast Cancer Patients: Results from a US Population-based Analysis
- (2014) Rebecca A. Nelson et al. ANNALS OF SURGICAL ONCOLOGY
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial
- (2014) Gunter von Minckwitz et al. LANCET ONCOLOGY
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
- (2012) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers
- (2011) T. R. Lester et al. BREAST CANCER RESEARCH AND TREATMENT
- The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients
- (2011) Soo Youn Bae et al. BREAST CANCER RESEARCH AND TREATMENT
- Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer
- (2010) So-Youn Jung et al. BREAST CANCER RESEARCH AND TREATMENT
- Metaplastic carcinoma of the breast
- (2010) Nao Okada et al. HUMAN PATHOLOGY
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now